FindTrial
Sign In

Misoprostol and endometrial polyp

The effect of misoprostol on removal endometrial polyp

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200305046702N2
Enrollment
30
Registered
2020-10-31
Start date
2020-07-22
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial polyp. Female infertility of uterine origin

Interventions

Intervention group:Each patient recieve tow tablet of 200 microgram misoprostol(cytotec):in the manner 200 micro gram vaginal and 200 micro gram oral at the same time.Afther eight hours each patient e

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Endometrial polyp in normal saline sonography Infertility 45>=Age>=18

Exclusion criteria

Exclusion criteria: Uterus malformation Sensitivity to prostaglandin analogs

Design outcomes

Primary

MeasureTime frame
Endometrial polyp removal. Timepoint: 8 hours after misoprostol administration. Method of measurement: Vaginal sonography, hystroscopy.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZohreh Pezeshkpour

Yazd University of Medical Sciences

z.pezeshkpour@stu.ssu.ac.ir+98 35 3824 7085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026